CD44 IN RHEUMATOID SYNOVITIS
CD44 IN RHEUMATOID SYNOVITIS
批准号:
6217141
负责人:
KATALIN MIKECZ
金额:
$22.63万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2000-02-29
关键词:
CD44 molecule SCID mouse arthritis articular cartilage athymic mouse cartilage transplantation cell cell interaction fibroblasts human tissue hyaluronate interleukin 1 laboratory mouse laboratory rat leukocyte activation /transformation molecular pathology monoclonal antibody proteoglycan rheumatoid arthritis synovitis tumor necrosis factor alpha xenotransplantation
中文摘要
这项研究计划涉及透明质酸(HA)受体的作用
CD 44在类风湿性滑膜炎滑膜病理中的作用我们有
在蛋白多糖和胶原诱导的关节炎小鼠中证实
单克隆抗CD 44抗体消除了关节肿胀,
炎性白细胞浸润。我们的研究结果表明,CD 44
参与多种细胞-细胞和细胞-基质相互作用,
炎症的部位。CD 44和HA介导的炎症反应
滑膜炎目前尚不清楚。CD 44存在于滑膜细胞上,
HA是滑液和细胞外基质的主要成分
在正常的关节。而CD 44和HA的含量则随着时间的延长而增加,
在炎症过程中非常明显。风湿性关节炎滑膜细胞
而活化的白细胞表达不表达的CD 44变体亚型
在正常滑膜中检测到。与正常关节相比,类风湿关节炎
滑膜组织产生HA分子,
基质和扩散到细胞外空间,从而影响关节
肿胀.白细胞,通过CD 44-HA相互作用,可以被募集,
由存在于滑膜间质室中的HA激活
组织.我们的初步结果表明,IL-1的产生和
TNF-α通过滑膜细胞被HA增强。此外,CD 44和
HA似乎与关节软骨的侵袭有关,
类风湿性血管翳
在这项研究中,我们将比较滑膜组织和细胞,从正常
和发炎的关节,在小鼠和人类系统中,
HA和CD 44的分子和功能特性。我们将
描述了一些调节和信号传导机制,
有助于持续的白细胞和滑膜成纤维细胞活化。
我们还打算确定是否异常的细胞基质和细胞
类风湿性滑膜中的相互作用可以通过调节
CD 44功能。体外实验的结果将传达给
破坏性滑膜炎嵌合模型的体内研究,
移植到SCID小鼠中的人类风湿性滑膜和软骨。我们
我相信,这里提出的研究结果将提供一个
更好地理解关节炎中CD 44和HA介导的事件
过程,并为治疗干预开辟新的途径,
类风湿关节炎
英文摘要
This research proposal concerns the role of the hyaluronan (HA) receptor
CD44 in synovial pathology during rheumatoid synovitis. We have
demonstrated in mice with proteoglycan- and collagen-induced arthritis
that a monoclonal anti-CD44 antibody eliminates joint swelling and
inflammatory leukocyte infiltration. Our results suggest that CD44
participates in a variety of cell-cell and cell-matrix interactions at
the site of inflammation. CD44- and HA-mediated events in inflammatory
synovitis are current not understood. CD44 is present on synovial cells,
and HA is a major constituent of synovial fluid and extracellular matrix
in the normal joint. However, the amounts of CD44 and HA increase
dramatically during inflammatory processes. Rheumatoid synovial cells
and activated leukocytes express CD44 variant isoforms that are not
detected in normal synovium. In contrast to normal joints, rheumatoid
synovial tissue produces HA molecules that are poorly associated with
matrix and diffuse into the extracellular space thus effecting joint
swelling. Leukocytes, via the CD44-HA interaction, can be recruited and
activated by HA present in the interstitial compartment of synovial
tissue. Our preliminary results suggest that the production of IL-1 and
TNF-alpha by synovial cells is augmented by HA. Furthermore, CD44 and
HA appear to be associated with the invasion of articular cartilage by
rheumatoid pannus.
In this study, we will compare synovial tissues and cells from normal
and inflamed joints, in both murine and human systems, with respect to
the molecular and functional properties of HA and CD44. We will
delineate some of the regulatory and signaling mechanisms which may
contribute to persistent leukocyte and synovial fibroblast activation.
We also intend to determine if abnormal cell-matrix and cell-cell
interactions in the rheumatoid synovium can be corrected by modulating
CD44 function. The results of in vitro experiments will be conveyed to
in vivo studies on a chimeric model of destructive synovitis, utilizing
human rheumatoid synovium and cartilage engrafted into SCID mice. We
believe that the findings of the studies proposed here will provide a
better understanding of CD44- and HA-mediated events in arthritic
processes, and open new avenues for therapeutic intervention in
rheumatoid arthritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune Recognition of Citrullinated Cartilage PG Aggrecan in Autoimmune Arthritis
-
批准号:8478814
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2013
-
负责人:KATALIN MIKECZ
-
依托单位:
Immune Recognition of Citrullinated Cartilage PG Aggrecan in Autoimmune Arthritis
-
批准号:8836393
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2013
-
负责人:KATALIN MIKECZ
-
依托单位:
Immune Recognition of Citrullinated Cartilage PG Aggrecan in Autoimmune Arthritis
-
批准号:8636402
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2013
-
负责人:KATALIN MIKECZ
-
依托单位:
Myeloid-derived Suppressor Cells in Autoimmune Arthritis
-
批准号:8227601
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2011
-
负责人:KATALIN MIKECZ
-
依托单位:
Myeloid-derived Suppressor Cells in Autoimmune Arthritis
-
批准号:8337403
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2011
-
负责人:KATALIN MIKECZ
-
依托单位:
MECHANISMS OF ARTHRITIS SUPPRESSION BY TSG-6 (TNFIP6)
-
批准号:6769002
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2004
-
负责人:KATALIN MIKECZ
-
依托单位:
MECHANISMS OF ARTHRITIS SUPPRESSION BY TSG-6 (TNFIP6)
-
批准号:7028874
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2004
-
负责人:KATALIN MIKECZ
-
依托单位:
MECHANISMS OF ARTHRITIS SUPPRESSION BY TSG-6 (TNFIP6)
-
批准号:7391693
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2004
-
负责人:KATALIN MIKECZ
-
依托单位:
MECHANISMS OF ARTHRITIS SUPPRESSION BY TSG-6 (TNFIP6)
-
批准号:6883250
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2004
-
负责人:KATALIN MIKECZ
-
依托单位:
MECHANISMS OF ARTHRITIS SUPPRESSION BY TSG-6 (TNFIP6)
-
批准号:7190581
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2004
-
负责人:KATALIN MIKECZ
-
依托单位:
CD44 IN RHEUMATOID SYNOVITIS
-
批准号:6299866
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2000
-
负责人:KATALIN MIKECZ
-
依托单位:
CD44 IN RHEUMATOID SYNOVITIS
-
批准号:6100717
-
项目类别:
-
资助金额:$22.63万
-
财政年份:1999
-
负责人:KATALIN MIKECZ
-
依托单位:
CD44 IN RHEUMATOID SYNOVITIS
-
批准号:2875461
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1998
-
负责人:KATALIN MIKECZ
-
依托单位:
ANTI-CD44 IMMUNOTHERAPY IN ARTHRITIS
-
批准号:2390563
-
项目类别:
-
资助金额:$8.13万
-
财政年份:1996
-
负责人:KATALIN MIKECZ
-
依托单位:
ANTI-CD44 IMMUNOTHERAPY IN ARTHRITIS
-
批准号:2683347
-
项目类别:
-
资助金额:$8.46万
-
财政年份:1996
-
负责人:KATALIN MIKECZ
-
依托单位:
ANTI-CD44 IMMUNOTHERAPY IN ARTHRITIS
-
批准号:2083850
-
项目类别:
-
资助金额:$7.71万
-
财政年份:1996
-
负责人:KATALIN MIKECZ
-
依托单位:
海外基金